Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

108 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comparison of Abiraterone and Combined Androgen Blockade Therapy for High-Risk Metastatic Hormone-Sensitive Prostate Cancer: A Propensity Score-Matched Analysis.
Matsumura N, Fujita K, Nishimoto M, Yamamoto Y, Kuwahara K, Nagai Y, Minami T, Hatanaka Y, Nozawa M, Morimoto Y, Tahara H, Uejima S, Esa A, Hirayama A, Yoshimura K, Uemura H. Matsumura N, et al. Among authors: esa a. Front Oncol. 2021 Dec 21;11:769068. doi: 10.3389/fonc.2021.769068. eCollection 2021. Front Oncol. 2021. PMID: 34993133 Free PMC article.
Phase II trial of zoledronic acid combined with androgen-deprivation therapy for treatment-naïve prostate cancer with bone metastasis.
Nozawa M, Inagaki T, Nagao K, Nishioka T, Komura T, Esa A, Kitagawa M, Imanishi M, Uekado Y, Ogawa T, Kajikawa H, Uejima S, Matsuyama H, Hara I, Uemura H. Nozawa M, et al. Among authors: esa a. Int J Clin Oncol. 2014 Aug;19(4):693-701. doi: 10.1007/s10147-013-0604-z. Epub 2013 Aug 3. Int J Clin Oncol. 2014. PMID: 23912936 Clinical Trial.
Zoledronic acid combined with androgen-deprivation therapy may prolong time to castration-resistant prostate cancer in hormone-naïve metastatic prostate cancer patients - A propensity scoring approach.
Nagao K, Matsuyama H, Nozawa M, Hara I, Nishioka T, Komura T, Esa A, Uejima S, Imanishi M, Uekado Y, Ogawa T, Kajikawa H, Uemura H. Nagao K, et al. Among authors: esa a. Asian J Urol. 2016 Jan;3(1):33-38. doi: 10.1016/j.ajur.2015.10.003. Epub 2015 Oct 31. Asian J Urol. 2016. PMID: 29264160 Free PMC article.
Glomus tumor of the kidney.
Sugimoto K, Yamamoto Y, Hashimoto K, Esa A, Okamoto S. Sugimoto K, et al. Among authors: esa a. Int J Urol. 2010 Feb;17(2):187-8. doi: 10.1111/j.1442-2042.2009.02433.x. Int J Urol. 2010. PMID: 20377837
108 results